Caliper Life Sciences Grants Patent License to Novartis

Caliper Life Sciences announced that Novartis has signed a multi-year license to Caliper’s patented non-invasive optical imaging methods.

Non-invasive optical imaging allows scientists to visualize, track and quantify biological processes at the molecular level with high throughput and relatively low cost, Caliper said.

The company added that more than 70 percent of major pharmaceutical companies, and 60 percent of major biotech companies hold licenses to Caliper optical imaging patents, and smaller biotechs are following suit “in increasing numbers.”